Physician

Ami Thakor Philipp, M.D.

According to 2025 Medicare claims, Ami Philipp, M.D. (NPI: 1699040782) practices allergy/immunology in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (NPI: 1235107566; TIN: 954373071) and primary practice location at 91326-4141.

Philipp's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 226 traditional Medicare patients, billed 5,174 HCPCS/CPT codes, and received $104,168 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,501 prescription claims across 237 beneficiaries totaling $1,879,675 in drug costs, led by Xolair (Omalizumab). DME data shows 142 claims. Open Payments data shows 1 records totaling $28. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $15,416 to $104,168. Similarly, Part D prescription costs have moved sharply higher in recent years, from $3,592 to $1,879,675. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $266 to $4,186.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	57	778	$15,416
2018	173	3,097	$58,481
2019	133	3,235	$65,470
2020	162	2,902	$72,333
2021	223	2,959	$74,965
2022	210	2,668	$63,424
2023	236	4,511	$90,443
2024	226	5,174	$104,168

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	28	106	$3,592
2016	N/R	16	$302
2017	21	40	$30,967
2018	106	443	$375,882
2019	134	678	$648,806
2020	138	860	$834,256
2021	185	1,112	$834,246
2022	192	1,285	$1,292,134
2023	227	1,348	$1,666,489
2024	237	1,501	$1,879,675

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	16	$80
2019	N/R	15	$60
2020	N/R	N/R	N/R
2021	N/R	13	$45
2022	N/R	15	$49
2023	N/R	78	$103,136
2024	N/R	142	$151,463

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	30	42	$141
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	52	52	$125
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	137	217	$98
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	41	44	$13
95165	Professional service for preparation and provision of 1 or more antigens	26	1,142	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xolair	Omalizumab	105	3,005	$413,795
Dupixent Syringe	Dupilumab	76	2,284	$300,685
Hizentra	Immun Glob G(Igg)/Pro/Iga 0-50	32	896	$227,988
Octagam	Immun Globg(Igg)/Malt/Iga Ov50	29	824	$177,850
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	30	866	$146,195

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	12	$75,525
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	18	$36,277
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	13	$35,924
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	41	$3,033
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	43	$499

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$28	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ami Thakor Philipp, M.D.?

Tedicare shows public-source Medicare data for Ami Thakor Philipp, M.D. (NPI 1699040782), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ami Thakor Philipp, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ami Thakor Philipp, M.D.?

Ami Thakor Philipp, M.D. is linked to THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (billing NPI 1235107566) in the available physician profile data.

Does Ami Thakor Philipp, M.D. have Open Payments data?

Ami Thakor Philipp, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.